title: [Blockade of proteasome activity disturbs the rhythm of synthesis of the protein marker of direct cell-cell interactions].
abstract: The effect of inhibition of proteasome activity on direct cell-cell interactions in primary hepatocyte cultures was studied. The circahoralian rhythm of protein synthesis was a marker of cell-cell communication. The addition of the proteasome inhibitor MG132 at doses of 10 or 20 μM to the medium with hepatocyte cultures for 19 h resulted in a significant reduction in the total pool of 3H-leucine in cells. The incorporation of leucine into proteins changed slightly or negligibly, whereas the content of free labeled leucine in hepatocytes decreased. The rhythm of protein synthesis was distorted compared to the control. The rhythm was restored by external organizers, such as gangliosides and melatonin, as well as by enhancing the activity of protein kinases--the key factor in the organization of the rhythm of protein synthesis. A short-term (3-h) exposure to MG132 did not change the pool of leucine, but the rhythm of protein synthesis was also disturbed. Thus, protein catabolism affects cell-cell interactions organizing the rhythm of protein synthesis. Another factor of the downregulation of the rhythm of protein synthesis, the secretion of proteins from the hepatocytes in vivo, which was shown in vivo in many studies, was also revealed in our study when measuring the content of proteins stained with Coomassie Brilliant Blue G250 in the medium with hepatocyte cultures.
authors.forename: V Ia
authors.initials: VIa
authors.lastname: Brodskiĭ
authors.forename: N P
authors.initials: NP
authors.lastname: Sharova
authors.forename: L A
authors.initials: LA
authors.lastname: Mal'chenko
authors.forename: D S
authors.initials: DS
authors.lastname: Konchenko
authors.forename: T K
authors.initials: TK
authors.lastname: Dubovaia
authors.forename: N D
authors.initials: ND
authors.lastname: Zvezdina
mesh_terms: D000818:Animals; D001692:Biological Transport; D015415:Biomarkers / Q000378:metabolism; D002450:Cell Communication / Q000187:drug effects; D005732:Gangliosides / Q000494:pharmacology; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D007976:Leupeptins / Q000494:pharmacology*; D008550:Melatonin / Q000494:pharmacology; D010507:Periodicity; D061251:Primary Cell Culture; D046988:Proteasome Endopeptidase Complex / Q000187:drug effects* / Q000378:metabolism; D061988:Proteasome Inhibitors / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects*; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014316:Tritium
chemical_list: D015415:Biomarkers; D005732:Gangliosides; D007976:Leupeptins; D061988:Proteasome Inhibitors; D014316:Tritium; D011494:Protein Kinases; D046988:Proteasome Endopeptidase Complex; D007930:Leucine; D008550:Melatonin; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde